These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 21220845)

  • 21. Biodistributions, myelosuppression, and toxicities in mice treated with an anti-CD45 antibody labeled with the alpha-emitting radionuclides bismuth-213 or astatine-211.
    Nakamae H; Wilbur DS; Hamlin DK; Thakar MS; Santos EB; Fisher DR; Kenoyer AL; Pagel JM; Press OW; Storb R; Sandmaier BM
    Cancer Res; 2009 Mar; 69(6):2408-15. PubMed ID: 19244101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitigation of radiation nephropathy after internal alpha-particle irradiation of kidneys.
    Jaggi JS; Seshan SV; McDevitt MR; Sgouros G; Hyjek E; Scheinberg DA
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1503-12. PubMed ID: 16503385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Engineered liposomes for potential alpha-particle therapy of metastatic cancer.
    Sofou S; Thomas JL; Lin HY; McDevitt MR; Scheinberg DA; Sgouros G
    J Nucl Med; 2004 Feb; 45(2):253-60. PubMed ID: 14960644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Theoretical estimation of absorbed dose to organs in radioimmunotherapy using radionuclides with multiple unstable daughters.
    Hamacher KA; Sgouros G
    Med Phys; 2001 Sep; 28(9):1857-74. PubMed ID: 11585217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted Alpha-Particle Therapy for Hematologic Malignancies.
    Jurcic JG
    J Med Imaging Radiat Sci; 2019 Dec; 50(4 Suppl 1):S53-S57. PubMed ID: 31253514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and bioactivity of 1,4,7,10-tetra-azacylododecane off',N'',N'''-tetraacetic acid (DOTA)-bismuth-conjugated anti-Tac antibody for alpha-emitter (212Bi) therapy.
    Junghans RP; Dobbs D; Brechbiel MW; Mirzadeh S; Raubitschek AA; Gansow OA; Waldmann TA
    Cancer Res; 1993 Dec; 53(23):5683-9. PubMed ID: 8242624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody MX35.
    Elgqvist J; Andersson H; Bäck T; Hultborn R; Jensen H; Karlsson B; Lindegren S; Palm S; Warnhammar E; Jacobsson L
    J Nucl Med; 2005 Nov; 46(11):1907-15. PubMed ID: 16269606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal tubulointerstitial changes after internal irradiation with alpha-particle-emitting actinium daughters.
    Jaggi JS; Seshan SV; McDevitt MR; LaPerle K; Sgouros G; Scheinberg DA
    J Am Soc Nephrol; 2005 Sep; 16(9):2677-89. PubMed ID: 15987754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha radioimmunotherapy using
    Cheal SM; McDevitt MR; Santich BH; Patel M; Yang G; Fung EK; Veach DR; Bell M; Ahad A; Vargas DB; Punzalan B; Pillarsetty NVK; Xu H; Guo HF; Monette S; Michel AO; Piersigilli A; Scheinberg DA; Ouerfelli O; Cheung NV; Larson SM
    Theranostics; 2020; 10(25):11359-11375. PubMed ID: 33052220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production of actinium-225 for alpha particle mediated radioimmunotherapy.
    Boll RA; Malkemus D; Mirzadeh S
    Appl Radiat Isot; 2005 May; 62(5):667-79. PubMed ID: 15763472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bismuth-213 and actinium-225 -- generator performance and evolving therapeutic applications of two generator-derived alpha-emitting radioisotopes.
    Morgenstern A; Bruchertseifer F; Apostolidis C
    Curr Radiopharm; 2012 Jul; 5(3):221-7. PubMed ID: 22642390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator.
    Su FM; Beaumier P; Axworthy D; Atcher R; Fritzberg A
    Nucl Med Biol; 2005 Oct; 32(7):741-7. PubMed ID: 16243650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Susceptibility of the human pathogenic fungi Cryptococcus neoformans and Histoplasma capsulatum to gamma-radiation versus radioimmunotherapy with alpha- and beta-emitting radioisotopes.
    Dadachova E; Howell RW; Bryan RA; Frenkel A; Nosanchuk JD; Casadevall A
    J Nucl Med; 2004 Feb; 45(2):313-20. PubMed ID: 14960655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted actinium-225 in vivo generators for therapy of ovarian cancer.
    Borchardt PE; Yuan RR; Miederer M; McDevitt MR; Scheinberg DA
    Cancer Res; 2003 Aug; 63(16):5084-90. PubMed ID: 12941838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nephrotoxicity profiles and threshold dose values for [177Lu]-DOTATATE in nude mice.
    Svensson J; Mölne J; Forssell-Aronsson E; Konijnenberg M; Bernhardt P
    Nucl Med Biol; 2012 Aug; 39(6):756-62. PubMed ID: 22445743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leveraging Bioorthogonal Click Chemistry to Improve
    Poty S; Carter LM; Mandleywala K; Membreno R; Abdel-Atti D; Ragupathi A; Scholz WW; Zeglis BM; Lewis JS
    Clin Cancer Res; 2019 Jan; 25(2):868-880. PubMed ID: 30352909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional response of kidney tissue after 177Lu-octreotate administration in mice.
    Schüler E; Rudqvist N; Parris TZ; Langen B; Helou K; Forssell-Aronsson E
    Nucl Med Biol; 2014 Mar; 41(3):238-47. PubMed ID: 24434014
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Pfannkuchen N; Bausbacher N; Pektor S; Miederer M; Rosch F
    Curr Radiopharm; 2018; 11(3):223-230. PubMed ID: 29866026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced renal toxicity of total body irradiation combined with radioimmunotherapy.
    Röttinger EM; Bartkowiak D; Bunjes D; Wennauer R; Dohr D
    Strahlenther Onkol; 2003 Oct; 179(10):702-7. PubMed ID: 14566479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.